cmAngio® vs iCAC Device

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 70/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

cmAngio®

by CureMetrix

iCAC Device

by Bunkerhill Health

AI Verdict

These tools are adjacent in their goal of leveraging AI for opportunistic cardiovascular risk assessment. cmAngio® focuses on detecting Breast Arterial Calcifications from mammograms, primarily aiding in women's health. In contrast, the iCAC Device analyzes non-contrast chest CT scans to quantify Coronary Artery Calcium, offering a broader cardiovascular risk assessment.

Choose cmAngio® if…

Choose cmAngio® if your primary goal is to leverage existing mammography screenings to assess cardiovascular risk in women. This tool is ideal for OB/GYN and radiology practices seeking to provide early, non-invasive insights into breast arterial calcifications (BAC) without requiring additional radiation or procedures, integrating seamlessly into mammography workflows.

View cmAngio® →

Choose iCAC Device if…

Choose the iCAC Device if you aim to opportunistically detect and quantify coronary artery calcium (CAC) from routine, non-contrast chest CT scans already performed for other indications. This tool is best suited for cardiology and radiology departments looking to add a valuable cardiovascular risk assessment to a broader patient population by utilizing existing CT data and providing quantitative Agatston unit estimates.

View iCAC Device →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	cmAngio®	iCAC Device
Pricing	Paid, out-of-pocket	Contact for pricing
Deployment	Cloud-based, integrates with any DICOM-compliant viewer	Software as a Medical Device (SaMD), integrates with PACS or DICOM router. Cloud-based (via Carebricks platform).
FDA Status	Cleared AI-estimated	Cleared AI-estimated
HIPAA	Yes AI-estimated	Unknown

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	cmAngio®	iCAC Device
Name	cmAngiou00ae	iCAC Device
Company	CureMetrix	Bunkerhill Health
Primary Detection Target	Breast Arterial Calcifications (BAC)	Coronary Artery Calcium (CAC)
Analyzed Imaging Modality	Full-Field Digital Mammography (FFDM) and Digital Breast Tomosynthesis (DBT) exams	Routine, non-contrast, non-gated chest CT scans
Key Output/Information Provided	Visualization of BAC location on a scorecard; BAC identification and reporting.	Estimates presence and quantity of coronary artery calcium (CAC); Visual representation of estimated CAC segmentation; Exact and four-category quantitative estimates of CAC burden in Agatston units.

Videos

Demos, reviews, and walkthroughs featuring cmAngio® and iCAC Device.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What types of medical images do cmAngiou00ae and iCAC Device analyze?

cmAngiou00ae is designed to analyze both Full-Field Digital Mammography (FFDM) and Digital Breast Tomosynthesis (DBT) exams. In contrast, the iCAC Device analyzes routine, non-contrast, non-gated chest CT scans.

What specific cardiovascular indicators do these AI tools detect?

cmAngiou00ae detects Breast Arterial Calcifications (BAC) on mammograms, which can provide insights into cardiovascular health. The iCAC Device detects and quantifies Coronary Artery Calcium (CAC) from chest CT scans, aiding in early cardiovascular disease detection.

How do cmAngiou00ae and iCAC Device present their findings?

cmAngiou00ae provides a visualization of BAC location on a scorecard and enables BAC identification and reporting. The iCAC Device outputs a visual representation of estimated CAC segmentation and delivers exact and four-category quantitative estimates of CAC burden in Agatston units.

What are the primary clinical benefits or use cases for each tool?

cmAngiou00ae improves healthcare for women by providing cardiovascular health insights and aiding early risk assessment without additional radiation or procedures during mammography. The iCAC Device supports opportunistic identification and quantification of CAC from existing CT scans to assist in early cardiovascular disease detection.

How do these tools integrate into existing clinical workflows?

cmAngiou00ae is cloud-based, compatible with any DICOM-compliant viewer, and boasts quick installation. The iCAC Device is a Software as a Medical Device (SaMD) that integrates with PACS or a DICOM router and can integrate with EHRs via the Carebricks platform.

Do these tools require additional patient procedures or radiation exposure?

cmAngiou00ae enables BAC identification and reporting without additional radiation for the patient or new procedures. The iCAC Device analyzes routine, non-contrast, non-gated chest CT scans, implying it utilizes existing imaging data for CAC assessment.

Which medical specialties are these AI tools most relevant for?

cmAngiou00ae is relevant for Cardiology AI, OB/GYN AI, and Radiology & Imaging AI specialties. The iCAC Device is primarily relevant for Cardiology and Radiology specialties.

More Comparisons

Assert-IQ vs Rapid Enterprise Platform

AISAP Cardio vs Rapid Enterprise Platform

AngioWaveNet vs Rapid Enterprise Platform

CorVista System with PH Add-On vs Rapid Enterprise Platform

More matchups featuring cmAngio® or iCAC Device

Backers

Who funded each tool's parent company.

cmAngio®

Keshif Ventures